Preclinical News and Research

RSS
Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models

Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Combination therapies targeting different cell types may be effective at treating colon cancer

Combination therapies targeting different cell types may be effective at treating colon cancer

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

New method generates detailed 3D images of the body's cancer cells

New method generates detailed 3D images of the body's cancer cells

Study lays foundation for treating drug, alcohol addicts with noninvasive brain stimulation

Study lays foundation for treating drug, alcohol addicts with noninvasive brain stimulation

Research suggests novel therapies to lower cardiovascular disease risk in rheumatoid arthritis patients

Research suggests novel therapies to lower cardiovascular disease risk in rheumatoid arthritis patients

New drug reduces symptoms of Rett syndrome in preclinical models

New drug reduces symptoms of Rett syndrome in preclinical models

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio team to present data on preclinical effectiveness of GeneRide platform

New study to explore link between diet, intestinal microbiota and cognitive decline

New study to explore link between diet, intestinal microbiota and cognitive decline

Researchers identify serotonin receptor that could be targeted to boost memory

Researchers identify serotonin receptor that could be targeted to boost memory

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Columbia University Irving Medical Center and NewYork-Presbyterian launch new Mothers Center

Columbia University Irving Medical Center and NewYork-Presbyterian launch new Mothers Center

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Newly developed technique allows researchers to study liver stage malaria

Newly developed technique allows researchers to study liver stage malaria

Scientists discover how potential new drug targets spinal muscular atrophy

Scientists discover how potential new drug targets spinal muscular atrophy

Alnylam achieves delivery of novel siRNAs conjugates to the central nervous system

Alnylam achieves delivery of novel siRNAs conjugates to the central nervous system

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Cognitive remediation services can feasibly be implemented in large systems of care

Cognitive remediation services can feasibly be implemented in large systems of care

Noise annoyance associated with increased risk of atrial fibrillation

Noise annoyance associated with increased risk of atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.